GO:0010585 L-glutamine secretion: Amino Acid Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010585 (L-glutamine secretion) is the controlled release of glutamine by a cell, a biological process that connects amino acid metabolism to intercellular signaling.
• Glutamine is the most abundant free amino acid in plasma and is secreted by multiple cell types, including pancreatic islet cells and enteroendocrine L cells.
• In pancreatic islets, L-glutamine stimulates glucagon secretion and participates in amino acid-induced insulin release, linking secretion to metabolic regulation.
• Enteroendocrine L cells respond to glutamine by secreting GLP-1, a process governed by activated glutamate dehydrogenase (GDH).
• Glutamine secretion supports intestinal physiology, including sodium absorption and redox homeostasis in enterocytes.
• Studying L-glutamine secretion requires integrated models such as CRISPR knockout, knock-in, overexpression, and metabolic flux assays.
Description
L-glutamine secretion (GO:0010585) is defined as the controlled release of glutamine by a cell. Glutamine is a conditionally essential amino acid and the most abundant free amino acid in circulation, and its secretion represents an active, regulated process rather than passive leakage. This process is central to intercellular communication because secreted glutamine can act as a metabolic substrate, a signaling molecule, and a precursor for nucleotides and glutathione. Researchers study L-glutamine secretion to understand how cells coordinate amino acid availability with endocrine and paracrine signals. In pancreatic islets, L-glutamine modulates glucagon secretion and contributes to amino acid-induced insulin release, indicating that glutamine secretion is metabolically coupled to hormone release. In the gut, enteroendocrine L cells secrete GLP-1 in response to glutamine, and this response is governed by glutamate dehydrogenase activity. Glutamine also supports intestinal sodium absorption and protects enterocytes from apoptosis by regulating glutathione-related redox homeostasis. These findings position L-glutamine secretion as a bridge between amino acid metabolism, redox balance, and endocrine function. Because glutamine is industrially produced and widely used in nutrition and clinical settings, understanding its secretion mechanisms has translational relevance. The process is therefore a valid target for genetic and pharmacological dissection using modern CRISPR-based models.
L-glutamine secretion At A Glance
| GO ID | GO:0010585 |
|---|---|
| GO term | L-glutamine secretion |
| Ontology | biological_process |
| Synonym | glutamine secretion |
| Definition | The controlled release of glutamine by a cell. |
| Major function | Regulated export of glutamine to support intercellular signaling and metabolic coordination. |
| Related processes | Amino acid-induced hormone secretion, GLP-1 secretion, glucagon secretion, insulin release. |
| Cell types | Pancreatic islet cells, enteroendocrine L cells, enterocytes. |
| Key regulators | Glutamate dehydrogenase (GDH), amino acid receptors, metabolic flux. |
What Is GO:0010585?
GO:0010585 (L-glutamine secretion) describes the controlled release of glutamine by a cell. It is a biological process in which glutamine, an amino acid, is exported from the cell in a regulated manner. The term is synonymous with glutamine secretion and excludes passive diffusion or cell lysis. It encompasses the signaling and metabolic events that trigger glutamine release, as well as the transport steps that move glutamine across the plasma membrane.
Why Is L-glutamine secretion Important in Cell Biology?
L-glutamine secretion is important because it links amino acid metabolism to endocrine and paracrine signaling, influencing glucose homeostasis, gut hormone release, and intestinal function. Dysregulation of glutamine handling has been implicated in metabolic and intestinal disorders, and glutamine supplementation is used clinically in nutrition and sports medicine. Understanding the controlled release of glutamine therefore has implications for diabetes, obesity, and gastrointestinal disease research.
• Glutamine is the most abundant free amino acid in plasma and a key intercellular nitrogen carrier.
• L-glutamine secretion modulates pancreatic glucagon secretion, linking amino acid availability to glucose counter-regulation.
• Glutamine-induced signaling in enteroendocrine L cells drives GLP-1 secretion, a major incretin pathway.
• Glutamine secretion supports intestinal sodium absorption and epithelial function.
• Secreted glutamine contributes to glutathione-related redox homeostasis and protects enterocytes from apoptosis.
• Glutamine supplementation enhances the liver glutamine-glutathione axis and heat shock factor-1 expression in trained animals.
• Amino acid-induced insulin release depends on glutamine metabolism in pancreatic islets.
• Glutamate dehydrogenase activity governs glutamine-elicited GLP-1 secretion, providing a druggable node.
• Industrial production of L-glutamine underscores its clinical and commercial importance.
• CRISPR models enable causal testing of genes controlling L-glutamine secretion.
What Happens During L-glutamine secretion?
Glutamine uptake and metabolic sensing
In simple terms: Cells first take up glutamine and sense its levels before they can release it in a controlled way.
L-glutamine secretion begins with glutamine availability and metabolic sensing. In pancreatic islets, L-glutamine participates in the stimulus-secretion coupling of amino acid-induced insulin release, indicating that islet cells metabolize glutamine and integrate its signal into secretory pathways. In enteroendocrine L cells, glutamine-induced signaling pathways via amino acid receptors trigger downstream responses, showing that glutamine is sensed as a signal rather than merely a nutrient. This sensing step is a prerequisite for the controlled release of glutamine and its metabolites.
Activation of glutamate dehydrogenase and signaling intermediates
In simple terms: An enzyme called glutamate dehydrogenase acts as a switch that helps convert the glutamine signal into a secretion signal.
Glutamine-elicited secretion of GLP-1 is governed by an activated glutamate dehydrogenase (GDH), which links glutamine metabolism to the secretory machinery in L cells. This step represents a key regulatory node where the metabolic fate of glutamine determines whether secretion occurs. In pancreatic islets, metabolic regulation by L-glutamine also influences glucagon secretion, supporting the concept that glutamine metabolism is coupled to hormone release. These findings indicate that GDH and related metabolic enzymes convert glutamine availability into a secretory signal.
Vesicular packaging and transport
In simple terms: Once the signal is set, glutamine or its carriers are packaged and moved toward the cell surface for release.
The controlled release of glutamine requires transport and packaging steps that move the amino acid across the plasma membrane. Although the exact vesicular machinery for glutamine secretion is not fully defined in the cited literature, the process is described as a controlled release rather than passive diffusion. In intestinal models, glutamine transport is coupled to sodium absorption, demonstrating that glutamine movement across membranes is physiologically regulated. These transport events are essential for the regulated export of glutamine from cells.
Secretory output and autocrine/paracrine effects
In simple terms: After release, glutamine acts on nearby cells or on the same cell to influence metabolism and survival.
Secreted glutamine can act locally to modulate cell behavior. In porcine enterocytes, L-glutamine attenuates apoptosis by regulating glutathione-related redox homeostasis, showing that glutamine availability and release influence cell survival. In endurance-exercise trained rats, L-glutamine supplementation enhances the liver glutamine-glutathione axis and heat shock factor-1 expression, indicating systemic effects of glutamine handling. These autocrine and paracrine actions define the physiological output of L-glutamine secretion.
Integration with hormone secretion
In simple terms: Glutamine release is often coordinated with the release of hormones such as insulin, glucagon, and GLP-1.
L-glutamine secretion is integrated with endocrine output. In pancreatic islets, L-glutamine is metabolically regulated and affects glucagon secretion, linking amino acid release to glucose counter-regulation. Amino acid-induced insulin release also depends on glutamine metabolism in rat pancreatic islets. In enteroendocrine L cells, glutamine-elicited GLP-1 secretion is governed by GDH, connecting glutamine handling to incretin release. Together, these studies show that L-glutamine secretion is not an isolated event but part of a coordinated secretory program.
Key Genes Involved in GO:0010585 L-glutamine secretion
The following genes and proteins have been experimentally linked to L-glutamine secretion, glutamine metabolism, or glutamine-responsive secretory pathways in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GLUD1 (GDH) | Glutamate dehydrogenase governs glutamine-elicited GLP-1 secretion | Key regulatory node for glutamine-dependent secretion in L cells |
| GCG (glucagon) | Glucagon secretion is metabolically regulated by L-glutamine | Links glutamine metabolism to glucose counter-regulation |
| INS (insulin) | Amino acid-induced insulin release depends on glutamine metabolism | Islet secretory coupling to glutamine |
| GLS (glutaminase) | Converts glutamine to glutamate, feeding metabolic signaling | Upstream of glutamine-dependent secretory pathways |
| GOT1/GOT2 | Aspartate aminotransferases participate in glutamine-derived metabolism | Metabolic flux supporting secretion |
| SLC1A5 | Glutamine transporter mediating cellular uptake | Determines intracellular glutamine available for secretion |
| SLC7A5 | Amino acid transporter coupled to glutamine efflux | Potential route for controlled glutamine release |
| SLC38A1/2 | Sodium-coupled glutamine transporters | Linked to intestinal sodium absorption and glutamine movement |
| GCLC | Glutamate-cysteine ligase, glutathione synthesis | Connects glutamine to redox homeostasis in enterocytes |
| GCLM | Glutamate-cysteine ligase modifier subunit | Redox regulation downstream of glutamine |
| GS (glutamine synthetase) | Synthesizes glutamine from glutamate | Determines intracellular glutamine pools for secretion |
| HSPA1A (HSF-1 target) | Heat shock protein induced by glutamine supplementation | Readout of glutamine-glutathione axis activation |
| HSF1 | Heat shock factor-1, regulated by glutamine supplementation | Transcription factor linking glutamine to stress response |
| GPX (glutathione peroxidase) | Antioxidant enzyme using glutathione | Redox effector downstream of glutamine |
| GSS | Glutathione synthetase | Glutathione pathway enzyme linked to glutamine metabolism |
| SLC6A19 | Neutral amino acid transporter in intestine | Potential contributor to glutamine absorption and release |
| TAS1R1/TAS1R3 | Amino acid taste receptors | Mediate glutamine-induced signaling in enteroendocrine cells |
| CASR | Calcium-sensing receptor | Amino acid receptor family member in secretory cells |
How Is L-glutamine secretion Regulated?
L-glutamine secretion is regulated at multiple levels. Metabolically, L-glutamine modulates pancreatic glucagon secretion, indicating that the secretory process responds to the metabolic state of the islet. In enteroendocrine L cells, glutamine-induced signaling pathways via amino acid receptors control downstream secretory responses. Glutamate dehydrogenase activity is a key determinant of glutamine-elicited GLP-1 secretion, showing that enzyme activation governs the secretory output. Amino acid-induced insulin release in rat pancreatic islets also depends on glutamine metabolism, further supporting metabolic regulation of glutamine-linked secretion. In addition, glutamine availability influences glutathione-related redox homeostasis, which can feedback on cell survival and secretory capacity. Systemic factors such as exercise training enhance the liver glutamine-glutathione axis and heat shock factor-1 expression, suggesting physiological regulation of glutamine handling.
L-glutamine secretion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GLUD1 | GLP-1 secretion and metabolic regulation | Knockout and point-mutation models in L cell lines |
| GCG | Glucagon secretion and glucose homeostasis | Islet-specific knockout and overexpression |
| INS | Amino acid-induced insulin release | Beta-cell knockout and knock-in |
| GCLC/GCLM | Glutathione-related redox homeostasis and apoptosis | Enterocyte knockout and overexpression |
| SLC38A1/2 | Intestinal sodium absorption and glutamine transport | Intestinal epithelial knockout and tagged knock-in |
Metabolic and endocrine disorders
L-glutamine secretion is linked to pancreatic islet function, where L-glutamine metabolically regulates glucagon secretion and participates in amino acid-induced insulin release. Dysregulation of these pathways could contribute to impaired glucose homeostasis and diabetes. Glutamine-elicited GLP-1 secretion in enteroendocrine L cells is governed by glutamate dehydrogenase, a pathway relevant to incretin-based therapies and metabolic disease. Therefore, genes controlling L-glutamine secretion are candidate modifiers in metabolic and endocrine disorders.
Intestinal disease and epithelial protection
Glutamine is critical for intestinal function. L-glutamine attenuates apoptosis in porcine enterocytes by regulating glutathione-related redox homeostasis, suggesting a protective role in intestinal injury. L-Glutamine also supports intestinal sodium absorption, with implications for diarrhea and electrolyte balance. These findings link L-glutamine secretion and handling to gastrointestinal disease and epithelial repair.
Redox stress and exercise-related physiology
Glutamine supplementation enhances the liver glutamine-glutathione axis and heat shock factor-1 expression in endurance-exercise trained rats, indicating that glutamine handling influences systemic redox and stress responses. This has implications for conditions involving oxidative stress and for nutritional strategies aimed at supporting glutathione status.
From L-glutamine secretion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is GLUD1 required for glutamine-elicited GLP-1 secretion? | GLUD1 knockout in enteroendocrine L cell lines |
| Does L-glutamine metabolically regulate glucagon secretion? | Islet-specific knockout or overexpression of glutamine metabolic genes |
| Which transporters mediate controlled glutamine release? | Knockout and tagged knock-in of SLC family transporters |
| Does glutamine secretion protect enterocytes from apoptosis? | Enterocyte knockout of glutathione pathway genes |
| How does glutamine supplementation affect liver glutathione? | Overexpression or knockout of HSF1 and glutathione enzymes in vivo |
| Do amino acid receptors mediate glutamine-induced signaling? | Knockout of TAS1R1/TAS1R3 or CASR in L cells |
How to Study the L-glutamine secretion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function of candidate genes | Test requirement of GLUD1 for GLP-1 secretion |
| CRISPR knock-in | Tagged or reporter alleles | Trace glutamine transporters and secretory vesicles |
| Secretion assay | Hormone or glutamine release | Measure insulin, glucagon, or GLP-1 output |
| Glutathione assay | Redox status | Assess glutamine-glutathione axis |
| Apoptosis assay | Cell survival | Evaluate enterocyte protection by glutamine |
| RNA-seq | Transcriptional changes | Identify glutamine-induced signaling pathways |
| Metabolic flux analysis | Glutamine utilization and conversion | Map metabolic fate of glutamine in islets |
| Immunoassay | Protein expression and phosphorylation | Measure HSF-1 and stress response |
Genetic perturbation with CRISPR
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes involved in L-glutamine secretion. For example, GLUD1 knockout can test whether glutamate dehydrogenase is required for glutamine-elicited GLP-1 secretion. Islet-specific perturbations can address metabolic regulation of glucagon secretion by L-glutamine. Transporters such as SLC family members can be tagged or knocked out to trace glutamine movement.
Metabolic and secretion assays
Secretion assays measure glutamine or hormone release from cells and islets. Amino acid-induced insulin release and glucagon secretion can be quantified in pancreatic islet models. GLP-1 secretion from enteroendocrine L cells provides a readout of glutamine-elicited secretory pathways. Glutamine and glutathione levels can be measured to assess the glutamine-glutathione axis.
Redox and apoptosis readouts
Because glutamine regulates glutathione-related redox homeostasis, assays for glutathione, reactive oxygen species, and apoptosis are informative. L-Glutamine attenuates apoptosis in porcine enterocytes, and this can be monitored by apoptosis assays and redox probes. Liver glutamine-glutathione axis and heat shock factor-1 expression can be measured after supplementation in exercise models.
Transcriptomic and signaling analysis
Glutamine-induced signaling pathways via amino acid receptors can be dissected with transcriptomics and phosphoproteomics in enteroendocrine L cell lines. Combining CRISPR perturbation with RNA-seq or proteomics helps identify downstream effectors of L-glutamine secretion.
How CRISPR Can Be Used to Study GO:0010585 L-glutamine secretion
Knockout
CRISPR knockout is used to delete genes such as GLUD1, GCG, or SLC transporters to test their requirement for L-glutamine secretion. For example, GLUD1 knockout can determine whether glutamate dehydrogenase is necessary for glutamine-elicited GLP-1 secretion. Knockout of glutamine metabolic enzymes in islets can reveal effects on glucagon and insulin release.
Point Mutation
Point mutation models introduce specific amino acid substitutions to dissect catalytic or regulatory residues. For instance, mutations in GLUD1 can test whether its enzymatic activity is required for glutamine-elicited secretion. Such models help distinguish catalytic function from scaffolding roles in L-glutamine secretion.
Knock-in
Knock-in of tags or reporters allows visualization and tracing of glutamine transporters and secretory proteins. Tagged SLC transporters can reveal localization and trafficking during controlled glutamine release. Reporter knock-ins can monitor promoter activity of genes involved in glutamine metabolism.
Overexpression
Overexpression models test sufficiency of candidate genes. Overexpressing glutamine transporters or metabolic enzymes can increase glutamine secretion or hormone release, providing gain-of-function evidence. Overexpression of HSF1 or glutathione enzymes can test effects on the glutamine-glutathione axis.
How EDITGENE Supports L-glutamine secretion Research
Researchers studying L-glutamine secretion-related genes often need to determine whether a candidate gene is causally involved in glutamine release, hormone secretion, or redox regulation. EDITGENE provides CRISPR-based cell models and screening services that enable precise, reproducible interrogation of these pathways.
Contact EDITGENE today to design your custom CRISPR model for L-glutamine secretion research.
Frequently Asked Questions About L-glutamine secretion
What is L-glutamine secretion (GO:0010585)?
L-glutamine secretion is the controlled release of glutamine by a cell, a biological process that connects amino acid metabolism to intercellular signaling.
What genes are involved in L-glutamine secretion?
Genes such as GLUD1, GCG, INS, GLS, and SLC family transporters have been linked to glutamine metabolism and glutamine-responsive secretion.
How is L-glutamine secretion regulated?
It is regulated by metabolic sensing, glutamate dehydrogenase activity, amino acid receptors, and redox status.
Why is L-glutamine secretion important for pancreatic islets?
L-glutamine metabolically regulates glucagon secretion and participates in amino acid-induced insulin release in pancreatic islets.
What is the role of glutamate dehydrogenase in glutamine secretion?
Activated glutamate dehydrogenase governs glutamine-elicited GLP-1 secretion in enteroendocrine L cells.
Does glutamine affect intestinal cells?
Yes, L-glutamine attenuates apoptosis in enterocytes via glutathione-related redox homeostasis and supports intestinal sodium absorption.
Can CRISPR be used to study L-glutamine secretion?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models enable causal testing of genes involved in glutamine secretion.
What diseases are linked to L-glutamine secretion?
Metabolic and endocrine disorders, intestinal disease, and redox-related conditions have been linked to glutamine handling.
How is glutamine secretion measured?
Secretion assays measure glutamine or hormone release, while glutathione and apoptosis assays assess downstream effects.
What cell models are used to study L-glutamine secretion?
Pancreatic islet cells, enteroendocrine L cell lines, and enterocytes are commonly used models.
Conclusion
L-glutamine secretion (GO:0010585) is a controlled biological process that links amino acid metabolism to endocrine and paracrine signaling. Experimental evidence shows that glutamine regulates glucagon and insulin release in pancreatic islets and drives GLP-1 secretion in enteroendocrine L cells through glutamate dehydrogenase. Glutamine also supports intestinal function and redox homeostasis, with implications for epithelial protection and systemic stress responses. Studying L-glutamine secretion with CRISPR-based models will help identify causal genes and pathways, advancing both basic biology and translational applications in metabolic and gastrointestinal disease.
References
- 1. Kusumoto I. 2001. Industrial production of L-glutamine.. J Nutr 131(9 Suppl):2552S-5S PMID: 11533312
- 2. Ostenson CG et al.. 1985. Evidence for metabolic regulation of pancreatic glucagon secretion by L-glutamine.. Acta Endocrinol (Copenh) 108(3):386-91 PMID: 3157289
- 3. Liu N et al.. 2018. l-Glutamine Attenuates Apoptosis in Porcine Enterocytes by Regulating Glutathione-Related Redox Homeostasis.. J Nutr 148(4):526-534 PMID: 29659951
- 4. Levine SA et al.. 1994. L-Glutamine in intestinal sodium absorption: lessons for physiology, pathobiology, and therapy for diarrhea.. Gastroenterology 106(6):1698-702 PMID: 8194718
- 5. Nakamura T et al.. 2020. Glutamine-induced signaling pathways via amino acid receptors in enteroendocrine L cell lines.. J Mol Endocrinol 64(3):133-143 PMID: 31940281
- 6. Petry ÉR et al.. 2015. L-glutamine supplementations enhance liver glutamine-glutathione axis and heat shock factor-1 expression in endurance-exercise trained rats.. Int J Sport Nutr Exerc Metab 25(2):188-97 PMID: 25202991
- 7. Sener A et al.. 1981. The stimulus-secretion coupling of amino acid-induced insulin release. Biosynthetic and secretory responses of rat pancreatic islet to L-leucine and L-glutamine.. Diabetologia 21(2):135-42 PMID: 7021285
- 8. Andersson LE et al.. 2018. Glutamine-Elicited Secretion of Glucagon-Like Peptide 1 Is Governed by an Activated Glutamate Dehydrogenase.. Diabetes 67(3):372-384 PMID: 29229616
